MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹682 Cr | ₹436 Cr | ₹354 Cr | ₹280 Cr | ₹245 Cr |
What is the latest Short Term Provisions ratio of MANKIND PHARMA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹682 Cr |
| Mar2024 | ₹436 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹245 Cr |
How is Short Term Provisions of MANKIND PHARMA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹682 Cr | 56.52 | |
| Mar2024 | ₹436 Cr | 23.12 | |
| Mar2023 | ₹354 Cr | 26.57 | |
| Mar2022 | ₹280 Cr | 13.98 | |
| Mar2021 | ₹245 Cr | - | |
Compare Short Term Provisions of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,884.1 Cr | -3.5% | -4.4% | -25.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -3.5% |
-4.4% |
-25.1% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses